Bb Biotech as of Sept. 30, 2014
Portfolio Holdings for Bb Biotech
Bb Biotech holds 26 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 15.0 | $369M | 3.9M | 94.78 | |
| Gilead Sciences (GILD) | 12.1 | $298M | 2.8M | 106.45 | |
| ISIS Pharmaceuticals | 10.5 | $258M | 6.6M | 38.83 | |
| Incyte Corporation (INCY) | 8.6 | $211M | 4.3M | 49.05 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.2 | $152M | 1.4M | 112.31 | |
| Medivation | 5.8 | $141M | 1.4M | 98.87 | |
| Alexion Pharmaceuticals | 4.9 | $121M | 727k | 165.82 | |
| Agios Pharmaceuticals (AGIO) | 4.7 | $116M | 1.9M | 61.35 | |
| Puma Biotechnology (PBYI) | 4.6 | $114M | 477k | 238.57 | |
| Pharmacyclics | 3.5 | $86M | 732k | 117.43 | |
| Regeneron Pharmaceuticals (REGN) | 3.4 | $84M | 233k | 360.52 | |
| Synageva Biopharma | 3.1 | $75M | 1.1M | 68.78 | |
| Alnylam Pharmaceuticals (ALNY) | 2.5 | $61M | 781k | 78.10 | |
| Halozyme Therapeutics (HALO) | 2.4 | $59M | 6.4M | 9.10 | |
| Radius Health | 2.3 | $58M | 2.7M | 21.00 | |
| Neurocrine Biosciences (NBIX) | 2.0 | $49M | 3.1M | 15.67 | |
| Receptos | 1.6 | $40M | 637k | 62.11 | |
| ImmunoGen | 1.4 | $34M | 3.2M | 10.59 | |
| Novavax | 1.3 | $31M | 7.5M | 4.17 | |
| Infinity Pharmaceuticals (INFIQ) | 1.3 | $31M | 2.3M | 13.42 | |
| Clovis Oncology | 1.0 | $25M | 558k | 45.36 | |
| Tesaro | 0.8 | $19M | 705k | 26.92 | |
| Theravance | 0.5 | $13M | 743k | 17.09 | |
| Achillion Pharmaceuticals | 0.5 | $13M | 1.3M | 9.98 | |
| Endocyte | 0.2 | $4.2M | 684k | 6.08 | |
| Cubist Pharmaceutic-cvr | 0.0 | $105k | 876k | 0.12 |
